Brief: Puma Biotechnology Reports Q4 And Full Year Financial Results

Puma Biotechnology

02/03/2023 21:12

March 2 (Reuters) - Puma Biotechnology Inc  PBYI.O :
    * PUMA BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR
FINANCIAL RESULTS
    * Q4 GAAP LOSS PER SHARE $0.12
    * Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.07
    * PRODUCT REVENUE, NET FOR Q4 OF 2022 WAS $53.7 MILLION,
COMPARED
TO $51.0 MILLION IN Q4 OF 2021
    * Q4 EARNINGS PER SHARE VIEW $0.05, REVENUE VIEW $57.1
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw771GNBa 
Further company coverage:  PBYI.O 

 ((Reuters.Briefs@thomsonreuters.com;))